Literature DB >> 6186039

Tumor induced immunosuppression.

J A Roth.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6186039

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


× No keyword cloud information.
  6 in total

Review 1.  Need for immunologic stimulators during immunosuppression produced by major cancer surgery.

Authors:  W H Cole; L Humphrey
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

2.  In vivo delayed rejection of tumors and inhibition of delayed-type hypersensitivity by HT-29 human colonic adenocarcinoma cell line.

Authors:  G J Pommier; F L Garrouste; D Bettetini; J M Culouscou; M M Remacle-Bonnet
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  Identification and characterization of a tumor-derived immunosuppressive glycoprotein from murine melanoma K-1735.

Authors:  J B Putnam; J A Roth
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

4.  Prognostic role of antibody reactivity to melanoma.

Authors:  D R Vlock; R DerSimonian; J M Kirkwood
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

5.  The human mixed lymphocyte-tumor cell interaction test. I. Positive autologous lymphocyte proliferative responses can be stimulated by tumor cells as well as by cells from normal tissues.

Authors:  E A Grimm; B M Vose; E W Chu; D J Wilson; M T Lotze; A A Rayner; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

6.  Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients.

Authors:  T Kubota; H Fujiwara; Y Ueda; T Itoh; T Yamashita; T Yoshimura; K Okugawa; Y Yamamoto; Y Yano; H Yamagishi
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.